Join us for this Q&A with Mike Auerbach, editor-in-chief at American Pharmaceutical Review and Debra Barberini, PhD, MaxCyte business development manager, as they discuss MaxCyte's role in the cell and gene therapy market, how they've evolved to meet the changing needs and demands of this industry, and innovations for the future.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.